EMED Mining Public Limited Announces Operations Update

NICOSIA, CYPRUS -- (Marketwired) -- 09/02/15 -- EMED Mining Public Limited (TSX: EMD) (AIM: EMED)

LSE: EMED; TSX: EMD 2 September 2015

EMED Mining Public Limited Operations Update

EMED Mining Public Limited ("EMED" or the "Company"), the European minerals development and exploration company, is pleased to provide an update on its continued progress towards the re-start of its Riotinto Copper Project ("Proyecto Riotinto").

Click on, or paste the following link into your web browser, to view the associated PDF document.

http://www.rns-pdf.londonstockexchange.com/rns/7771X_1-2015-9-1.pdf

CONTACTS:

----------------------------------------------------------------------------
                              Roger Davey/Alberto
EMED Mining                   Lavandeira                    +34 959 59 28 50
----------------------------------------------------------------------------
Canaccord Genuity (Nomad and  Henry Fitzgerald-O'Connor/
 Broker)                      Oliver Donaldson              +44 207 523 8000
----------------------------------------------------------------------------
Brandon Hill Capital (Broker) Oliver Stansfield             +44 203 463 5061
----------------------------------------------------------------------------
4C Communications (Investor
 Relations Europe)            Carina Corbett                +44 203 170 7973
----------------------------------------------------------------------------
Roth Investor Relations
 (Investor Relations North
 America)                     Michelle Roth                 +1 732 792 2200
----------------------------------------------------------------------------
Walbrook PR (Media Relations) Nick Rome/ Guy McDougall      +44 207 933 8783
----------------------------------------------------------------------------

This information is provided by RNS The company news service from the London Stock Exchange

Contact:
RNS
Customer Services
0044-207797-4400
[email protected]
http://www.rns.com

Source: EMED Mining Public Limited

You May Also Be Interested In

• Dr. James Charasika Scholarship for Medical Students Opens 2026 Application Cycle for Undergraduate Pre-Medical Candidates Nationwide
• Belite Bio Completes Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Tinlarebant for the Treatment of Stargardt Disease Type 1
• Dr. Yorell Manon-Matos Scholarship for Healthcare Students Announces 2027 Application Cycle for Aspiring Medical Professionals Nationwide